{"version":"4.5.2","hitCount":1,"request":{"query":"EXT_ID:23439384","resultType":"core","synonym":false,"page":1,"pageSize":25},"resultList":{"result":[{"id":"23439384","source":"MED","pmid":"23439384","doi":"10.1016/j.neuint.2013.02.017","title":"Expression and differential response to haloperidol treatment of Cyclon/CCDC86 mRNA in schizophrenia patients.","authorString":"Chervenkov T, Shishkov R, Tonchev AB.","authorList":{"author":[{"fullName":"Chervenkov T","firstName":"Trifon","lastName":"Chervenkov","initials":"T"},{"fullName":"Shishkov R","firstName":"Rinaldo","lastName":"Shishkov","initials":"R"},{"fullName":"Tonchev AB","firstName":"Anton B","lastName":"Tonchev","initials":"AB"}]},"journalInfo":{"issue":"6","volume":"62","journalIssueId":2027937,"dateOfPublication":"2013 May","monthOfPublication":5,"yearOfPublication":2013,"printPublicationDate":"2013-05-01","journal":{"title":"Neurochemistry international","medlineAbbreviation":"Neurochem Int","essn":"1872-9754","isoabbreviation":"Neurochem. Int.","issn":"0197-0186","nlmid":"8006959"}},"pubYear":"2013","pageInfo":"870-872","abstractText":"A gene known as Cyclon (cytokine-induced protein with coiled-coil domain) or CCDC86 (coiled-coil domain-containing protein 86) is known for its expression in leukocytes in mice, where it regulates the immune response. We investigated whether Cyclon/CCDC68 is expressed in leukocytes of schizophrenia patients and whether it might be used as a biological marker for the disease endophenotype segregation. We examined the level of mRNA of Cyclon/CCDC68 in white blood cells obtained from schizophrenia patients in relapse and remission as well as in healthy controls. The mRNA of Cyclon/CCDC68 was expressed by white blood cells of both schizophrenia patients and healthy controls. There was a dichotomous change in the levels of Cyclon/CCDC68 of relapsed patients before and after treatment. High Cyclon/CCDC68 levels were associated with a recent disease and presence of psychotic symptoms, while low levels were associated with a long duration of the disease and an absence of psychotic symptoms. These data indicate that Cyclon/CCDC68 levels correlate with the clinical presentation of relapsed schizophrenia. Cyclon/CCDC68 might be involved in the immune system disturbances observed in schizophrenia.","affiliation":"Laboratory of Immunology, University Hospital St. Marina, Varna, Bulgaria.","language":"eng","pubModel":"Print-Electronic","pubTypeList":{"pubType":["Journal Article"]},"meshHeadingList":{"meshHeading":[{"majorTopic_YN":"N","descriptorName":"Leukocytes","meshQualifierList":{"meshQualifier":[{"abbreviation":"DE","qualifierName":"drug effects","majorTopic_YN":"N"},{"abbreviation":"IM","qualifierName":"immunology","majorTopic_YN":"N"},{"abbreviation":"ME","qualifierName":"metabolism","majorTopic_YN":"N"}]}},{"majorTopic_YN":"N","descriptorName":"Humans"},{"majorTopic_YN":"N","descriptorName":"Haloperidol","meshQualifierList":{"meshQualifier":[{"abbreviation":"PD","qualifierName":"pharmacology","majorTopic_YN":"Y"},{"abbreviation":"TU","qualifierName":"therapeutic use","majorTopic_YN":"N"}]}},{"majorTopic_YN":"N","descriptorName":"Nuclear Proteins","meshQualifierList":{"meshQualifier":[{"abbreviation":"BI","qualifierName":"biosynthesis","majorTopic_YN":"Y"},{"abbreviation":"GE","qualifierName":"genetics","majorTopic_YN":"Y"}]}},{"majorTopic_YN":"N","descriptorName":"RNA, Messenger","meshQualifierList":{"meshQualifier":[{"abbreviation":"GE","qualifierName":"genetics","majorTopic_YN":"Y"}]}},{"majorTopic_YN":"N","descriptorName":"Antipsychotic Agents","meshQualifierList":{"meshQualifier":[{"abbreviation":"PD","qualifierName":"pharmacology","majorTopic_YN":"Y"},{"abbreviation":"TU","qualifierName":"therapeutic use","majorTopic_YN":"N"}]}},{"majorTopic_YN":"N","descriptorName":"Treatment Outcome"},{"majorTopic_YN":"N","descriptorName":"Polymerase Chain Reaction"},{"majorTopic_YN":"N","descriptorName":"Schizophrenia","meshQualifierList":{"meshQualifier":[{"abbreviation":"DT","qualifierName":"drug therapy","majorTopic_YN":"N"},{"abbreviation":"IM","qualifierName":"immunology","majorTopic_YN":"N"},{"abbreviation":"ME","qualifierName":"metabolism","majorTopic_YN":"Y"}]}},{"majorTopic_YN":"N","descriptorName":"Adult"},{"majorTopic_YN":"N","descriptorName":"Middle Aged"},{"majorTopic_YN":"N","descriptorName":"Female"},{"majorTopic_YN":"N","descriptorName":"Male"},{"majorTopic_YN":"N","descriptorName":"Young Adult"}]},"chemicalList":{"chemical":[{"name":"RNA, Messenger","registryNumber":"0"},{"name":"Antipsychotic Agents","registryNumber":"0"},{"name":"Haloperidol","registryNumber":"52-86-8"},{"name":"Nuclear Proteins","registryNumber":"0"},{"name":"cyclon protein, human","registryNumber":"0"}]},"subsetList":{"subset":[{"code":"IM","name":"Index Medicus"}]},"fullTextUrlList":{"fullTextUrl":[{"availability":"Subscription required","availabilityCode":"S","documentStyle":"doi","site":"DOI","url":"http://dx.doi.org/10.1016/j.neuint.2013.02.017"}]},"isOpenAccess":"N","inEPMC":"N","inPMC":"N","hasPDF":"N","hasBook":"N","citedByCount":0,"hasReferences":"Y","hasTextMinedTerms":"N","hasDbCrossReferences":"Y","dbCrossReferenceList":{"dbName":["UNIPROT"]},"hasLabsLinks":"N","hasTMAccessionNumbers":"N","dateOfCompletion":"2013-10-22","dateOfCreation":"2013-04-08","electronicPublicationDate":"2013-02-21","firstPublicationDate":"2013-02-21"}]}}